Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-Fraction Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy (A-SMART).
John Michael BryantRussell F PalmRoberto HerreraAnshul SaxenaSarah E HoffeDae Won KimAdeel KaiserAntonio UcarJason FlemingFernando De ZarragaPamela HodulSantiago AparoHoracio AsbunMokenge MalafaRamon JimenezJason DenboJessica M FrakesMichael D ChuongPublished in: Cancer control : journal of the Moffitt Cancer Center (2023)
A-SMART is associated with encouraging LRC and OS in elderly patients with initially inoperable PDAC. This novel non-invasive treatment strategy appears to be well-tolerated in patients with advanced age and should be considered in this population that has limited treatment options.